Use of 'N-in-One' dosing to create an in vivo pharmacokinetics database for use in developing structure-pharmacokinetic relationships

Journal of Pharmaceutical Sciences

Volumn 88, Issue 3, 1999, Pages 313-318

  Shaffer, Joel E ^a   Adkison, Kimberly K ^a   Halm, Kathy ^a,b   Hedeen, Kevin ^a   Berman, Judd ^a  

^a GLAXOSMITHKLINE   (United States)

^b Thermo Finnigan   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMIDE; ANILINE; DIMETHYL SULFONE; METHYL GROUP; NITROGEN; PHENYL GROUP; SULFONAMIDE; SULFONYLUREA; UREA;

ARTICLE; DISTRIBUTION VOLUME; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG HALF LIFE; DRUG METABOLISM; DRUG STRUCTURE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; REGRESSION ANALYSIS;

EID: 0033008412     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980292q     Document Type: Article

References (11)

1. Ecker, D. J.; Crooke, S. T. Combinatorial drug discovery: which methods will produce the greatest value? Bio/Technology 1995, 3, 351-60.
2. Berman, J.; Halm, K.; Adkison, K.; Shaffer, J. Simultaneous Pharmacokinetic Screening of a Mixture of Compounds in the Dog Using APCI/LC/MS/MS Analysis for Increased Throughput. J. Med. Chem. 1997, 40, 827-829.
3. Olah, T. V.; MCLoughlin, D. A.; Gilbert, J. D. The simultaneous determination of mixtures of drug candidates by liquid chromatography atmospheric pressure chemical ionization mass spectrometry as an in vivo drug screening procedure. Rapid Commun. Mass Spectrom. 1997, 11, 17-23.
4. Allen, M. C.; Shah, T. S.; Day, W. W. Rapid determination of oral pharmacokinetics and plasma free fraction using cocktail approaches: Methods and application. Pharm. Res. 1998, 15, 93-97.
5. Toon, S.; Rowland, M. Structure-Pharmacokinetic Relationships Among the Barbiturates in the Rat. J. Pharmacol. Exp. Ther. 1983, 225, 752-763.
6. Henschel, L.; Hoffmann, A. Assessment of Biotransformation Capacity After Oral Administration of Various Model Substances as a Cocktail. Z. Gastroenterol. 1991, 29, 645-649.
7. Jenner, P. J.; Ellard, G. A.; Gruer, P. J. K.; Aber, V. R. A comparison of the blood levels and urinary excretion of ethionamide and prothionamide in man. J. Antimicrob. Chemother. 1984, 13, 267-277.
8. Jenner, P. J.; Smith, S. E. Plasma levels of ethionamide and prothionamide in a volunteer following intravenous and oral dosages. Lepr. Rev. 1987, 58, 31-37.
9. Guttendorf, R. J. The Emerging Role of A.D.M.E. in Optimizing Drug Discovery and Design. http://www.awod.com/netsci/ Science/Special/feature06.html, Feb 1996.
10. Rodrigues, A. D. Preclinical Drug Metabolism in the Age of High-Throughput Screening: An Industrial Perspective. Pharm. Res. 1997, 14, 1504-1510.
11. Andrews, R. C., Brown, P. J., Cadilla, R., Drewry, D. H., Luzzio, M. J., Marron, B. E. and Nobel, S. A. Preparation and formulation of piperdinyloxazoles as α/c adrenergic receptor antagonists. PCT Int. Appl. WO 9616049, 81 pp, CODEN: P1XXD2.